Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PUT
Zimmer Biomet
ZBH
$18.4B
| $26.4M | 0.01% |
+244,300
| New | +$26.7M |
|
927
Globe Life
GL
$14.3B
| $26.3M | 0.01% |
248,147
-2,317
| -0.9% | -$222K |
|
928
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $26.3M | 0.01% |
+180,300
| New | +$26.1M |
|
929
CALL
American Airlines Group
AAL
$10.6B
| $26.2M | 0.01% |
2,335,000
-8,151,500
| -78% | -$86.2M |
|
930
PUT
Lam Research
LRCX
$390B
| $26.2M | 0.01% |
+321,000
| New | +$27.9M |
|
931
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $26.2M | 0.01% |
419,868
+83,125
| +25% | +$5.01M |
|
932
Progress Software
PRGS
$1.76B
| $26.1M | 0.01% |
388,096
+215,034
| +124% | +$12.3M |
|
933
Hormel Foods
HRL
$13.8B
| $26.1M | 0.01% |
824,098
+135,410
| +20% | +$4.3M |
|
934
Iridium Communications
IRDM
$5.29B
| $26.1M | 0.01% |
856,901
+137,924
| +19% | +$3.76M |
|
935
APA Corp
APA
$13.3B
| $26M | 0.01% |
1,064,365
-729,393
| -41% | -$20.5M |
|
936
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $26M | 0.01% |
644,400
-5,280,000
| -89% | -$196M |
|
937
PUT
Cadence Design Systems
CDNS
$93.4B
| $26M | 0.01% |
+96,000
| New | +$26.5M |
|
938
Nordson
NDSN
$17.3B
| $26M | 0.01% |
98,858
-32,370
| -25% | -$7.91M |
|
939
PUT
Advance Auto Parts
AAP
$3.49B
| $25.9M | 0.01% |
+665,000
| New | +$35.3M |
|
|
GAP
940
PUT
The Gap Inc
GAP
$7.37B
| $25.9M | 0.01% |
+1,175,000
| New | +$26.1M |
|
941
Flex
FLEX
$44.8B
| $25.9M | 0.01% |
774,856
+231,572
| +43% | +$7.12M |
|
942
Charles River Laboratories
CRL
$12.8B
| $25.8M | 0.01% |
130,826
-34,379
| -21% | -$7.14M |
|
943
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
| $25.8M | 0.01% |
60,887
+13,219
| +28% | +$5.37M |
|
944
PUT
Hasbro
HAS
$13.2B
| $25.7M | 0.01% |
+355,000
| New | +$23M |
|
945
EPAM Systems
EPAM
$5.09B
| $25.6M | 0.01% |
128,629
+13,981
| +12% | +$2.8M |
|
946
Ionis Pharmaceuticals
IONS
$9.4B
| $25.5M | 0.01% |
637,032
+21,358
| +3% | +$994K |
|
947
RXO
RXO
$3.58B
| $25.4M | 0.01% |
908,873
+590,530
| +186% | +$16.7M |
|
948
Regency Centers
REG
$14.1B
| $25.4M | 0.01% |
351,849
-10,961
| -3% | -$759K |
|
949
Avantor
AVTR
$9.19B
| $25.4M | 0.01% |
981,952
+401,642
| +69% | +$9.86M |
|
950
Amdocs
DOX
$6.22B
| $25.4M | 0.01% |
290,376
+17,097
| +6% | +$1.44M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.